ReviewSeminars in vascular surgery2021
Epidemiology of end-stage kidney disease.
Review in Seminars in vascular surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
106 citing papers in PubMed, 2 syntheses or guidelines pooled it, 159 citations in OpenAlex.
- Impact of Vascular Anastomosis Time on Kidney Transplant Outcomes - A Systematic Review.Transplant international : official journal of the European Society for Organ Transplantation · 2026Pooled it
- Comparison of intraoperative and postoperative outcomes between open and robotic-assisted kidney transplantation: a meta-analysis and systematic review.Journal of robotic surgery · 2025Pooled it
- Bufalin post-transcriptionally suppresses STAT3 to alleviate renal ferroptosis and tubulointerstitial fibrosis in diabetic kidney disease.Renal failure · 2026Article
- Machine learning prediction of CKD progression in hyperglycemic elderly adults: a prospective community cohort study.Renal failure · 2026Article
- Gut Dysbiosis, Uremic Toxins, and NLRP3 Signaling in Chronic Kidney Disease: From Mechanistic Evidence to Clinical Biomarker Evaluation.Diagnostics (Basel, Switzerland) · 2026Review
- Pediatric kidney transplant disparities.World journal of clinical pediatrics · 2026Article
- Triglyceride-glucose index associated with the risk of future renal function decline: a 13-year prospective cohort study.Scientific reports · 2026Article
- Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation.The pharmacogenomics journal · 2026Article
- Article
- Robotic kidney transplantation with deceased donor grafts: a comparative analysis of outcomes following donation after brain death and donation after circulatory death.Journal of robotic surgery · 2026Article
- Article
- Long-term mortality trends and disparities in renal failure across the United States, 1999 to 2024: A nationwide population-based ecological time-trend study.The Journal of international medical research · 2026Article
- Understanding the healthcare services and social support needs of patients with end-stage kidney disease in Ghana.BMC nephrology · 2026Article
- From comics to care: exploring the education potential of graphic novel in organ transplantation journey.Medical humanities · 2026Article
- Article
- Hematological and immune cell changes in complete blood count before and after hemodialysis.Scientific reports · 2026Article
- Serum PCSK9 level as a potential biomarker relating to age, cholesterol and predicting major adverse cardiovascular event risk in hemodialysis patients.International urology and nephrology · 2026Article
- Article
- Prevalence and Associated Factors of Renal Disease in Saudi Residents Attending Primary Health Care Centers in Riyadh, Saudi Arabia: Cross-Sectional Study.JMIR public health and surveillance · 2026Article
- Primary Care Involvement and Health Care Utilization Among Patients With End-Stage Kidney Disease.JAMA network open · 2026Article
46 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
End-stage kidney disease (ESKD) is a common and morbid disease that affects patients' quality and length of life, representing a large portion of health care expenditure in the United States. These patients commonly have associated diabetes and cardiovascular disease, with high rates of cardiovascular-related death. Management of ESKD requires renal replacement therapy via dialysis or transplantation. While transplantation provides the greatest improvement in survival and quality of life, the vast majority of patients are treated initially with hemodialysis. However, outcomes differ significantly among patient populations. Barriers in access to care have particularly affected at-risk populations, such as Black and Hispanic patients. These patients receive less pre-ESKD nephrology care, are less likely to initiate dialysis with a fistula, and wait longer for transplants-even in pediatric populations. Priorities for ESKD care moving into the future include increasing access to nephrology care in underprivileged populations, providing patient-centered care based on each patient's "life plan," and focusing on team-based approaches to ESKD care. This review explores ESKD from the perspective of epidemiology, costs, vascular access, patient-reported outcomes, racial disparities, and the impact of the COVID-19 crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.